NCT03756168已完成不适用
Clinical Evaluation of the Safety and Efficacy of a 1060 nm Diode Laser for Non-invasive Fat Reduction of the Flanks
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 2
- 主要终点
- Change in the Percentage of Fat Thickness From Baseline to 12-weeks Post-treatment
研究概览
简要总结
The objective of this clinical study is to assess the safety and efficacy of using a 1060 nm diode laser for non-invasive fat reduction of the flanks.
详细描述
Open-label, baseline-controlled, evaluator-blind, multi-center study evaluating a 1060 nm diode laser for non-invasive fat reduction of the flanks. The study will enroll up to 50 subjects requesting non-invasive lipolysis of the flanks. Each subject will receive a single study treatment. Subjects will be followed at six weeks and twelve weeks post-treatment. Twelve week outcome will be compared to baseline.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •able to read, understand and voluntarily provide written informed consent
- •healthy male or female > 18 years of age seeking treatment for unwanted fat in the abdomen
- •BMI score is less then 30
- •agree to not making any major changes in their diet or lifestyle during the course of the study
- •able and willing to comply with the treatment / follow up schedule and requirements
- •women of child-bearing age are required to be using a reliable method of birth control at least 3 months prior to study enrolment and for the duration of the study, have a negative urine pregnancy test baseline
排除标准
- •pregnant in the last 3 months intending to become pregnant, postpartum or nursing in the last 6 months
- •any previous liposuction / lipo-sculpture or any type of surgical procedure in the treatment area in the past 12 months
- •history of immunosuppression / immune deficiency disorders including AIDS and HIV infection, or use of immunosuppressive medications, 6 month prior to and during the course of the study
- •History of hyperlipidemia, diabetes, hepatitis, blood coagulopathy or excessive bleeding
- •Use of antiplatelet medications (81 mg of acetylsalicylic acid daily is permitted), anticoagulants, thrombocytes or any-inflammatory medications within 2 weeks of treatment
- •Having a history of skin cancer or any other cancer in the area to be treated, including presence of malignant or pre-malignant pigmented lesions
- •Having a permanent implant in the treatment area such as a metal plate or injected chemical substance such as silicone pr parenteral gold therapy (gold sodium thiomalate)
- •Use of medications, herbs or food supplements and vitamins known to induce photosensitivity to light exposure at the wavelength used history of photosensitivity disorder
- •Suffering from significant skin conditions in the treatment area or inflammatory skin conditions including but not limited to open lacerations, abrasions, herpes sores, cold sores, active infections
- •Tattoos in the treatment area
- •Poor quality skin (laxity)
- •Abdominal wall, muscular abnormality or hernia on physical examination
- •Unstable weight within the last 6 months (+ or - 3% weight change in the prior six months)
- •Participation in another clinical study involving the same anatomical areas within the last 6 months
- •History of keloid and hypertrophic scar formation or poor wound healing in the treatment area
- •As per the investigators discretion any physician or mental condition which may make it unsafe for the subject to participate
研究组 & 干预措施
All subjects
Experimental
干预措施: 1060nm Diode laser (Device)
结局指标
主要结局
Change in the Percentage of Fat Thickness From Baseline to 12-weeks Post-treatment
时间窗: Week 12
Change in the percentage of fat thickness of the adipose layer as measured by ultrasound at 12 weeks post-treatment as compared to baseline.
次要结局
- Change in Abdominal Circumference From Baseline to 12 Weeks Post-treatment(Week 12)
- Subject Satisfaction(Week 12)
- Treatment Pain(Day 1)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Analysis of the Performance of 1060 nm Diode and Radio Frequency Prior to AbdominoplastyAdipose Tissue AtrophyNCT04616898Venus Concept12
已完成
不适用
Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)Fat AtrophyNCT03756350Venus Concept30
已完成
3 期
Evaluation of clinical use of 440nm diode laser with flap surgery in management of periodontitis - A clinical trialCTRI/2022/10/046490DR VINEET V13
招募中
1 期
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed GlioblastomaGlioblastomaNCT04443010Philogen S.p.A.226
已完成
不适用
Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat ReductionAdipose Tissue AtrophyNCT04012814Venus Concept39